D&D Pharmatech

D&D Pharmatech is a biotech company that develops and commercializes therapeutics for the treatment of neurodegenerative and fibrotic diseases. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

D&D Pharmatech

D&D Pharmatech is a biotech company that develops and commercializes therapeutics for the treatment of neurodegenerative and fibrotic diseases. Read more

Sung Mook Lim's photo - CEO of D&D Pharmatech

CEO

Sung Mook Lim

CEO Approval Rating

90/100

Founded:

2014

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

D&D PHARMATECH TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

SK Biopharmaceuticals is D&D Pharmatech's #1 competitor. SK Biopharmaceuticals's headquarters is in Seongnam, Gyeongsangbugdo, and was founded in 2011. Like D&D Pharmatech, SK Biopharmaceuticals also works within the Pharmaceuticals sector. SK Biopharmaceuticals generates NaN% of D&D Pharmatech's revenue.

Orum Therapeutics is one of D&D Pharmatech's top rivals. Orum Therapeutics was founded in Cambridge, Massachusetts} in 2016. Orum Therapeutics operates in the Pharmaceuticals industry. Compared to D&D Pharmatech, Orum Therapeutics generates $2M less revenue.

Dong-A ST is one of D&D Pharmatech's top competitors. Dong-A ST is a Public company that was founded in 2013 in Seoul, Gyeongsangbugdo. Dong-A ST is in the Pharmaceuticals industry. Compared to D&D Pharmatech, Dong-A ST has NaN fewer employees.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $3.5M a good estimate for D&D Pharmatech's revenue?

D&D Pharmatech Acquisitions

No recent acquisitions found related to D&D Pharmatech

D&D Pharmatech Funding History

Since D&D Pharmatech was founded in 2014, it has participated in 2 rounds of funding. In total D&D Pharmatech has raised $155.9M. D&D Pharmatech's last funding round was on Aug 2019 for a total of $137.1M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Aug 2019
$137.1M

Smilegate Investment

Series A
Apr 2018
$18.8M

Since D&D Pharmatech was founded in 2014, it has participated in 2 rounds of funding. In total D&D Pharmatech has raised $155.9M. D&D Pharmatech's last funding round was on Aug 2019 for a total of $137.1M

D&D Pharmatech Investments

No recent investments found related to D&D Pharmatech

D&D Pharmatech News

August 15, 2019The Pharma Letter

BRIEF-US and Korean investors help D&D Pharmatech to go big in Series B

D&D Pharmatech, the parent company of Neuraly, Precision Molecular and Theraly Fibrosis, has raised $... See more »
August 15, 2019Asian Venture Capital Journal

Korean biotech player gets $137m Series B

D&D Pharmatech, a South Korean biotechnology company, has raised a $137 million Series B round from a... See more »
August 14, 2019FierceBiotech

D&D bags $137M to fund midphase Alzheimer's, Parkinson's trials

D&D Pharmatech has raised $137.1 million to advance treatments for neurodegenerative diseases and fib... See more »

D&D Pharmatech Press Releases

March 3, 2020StreetInsider

CORRECTING and REPLACING Neuraly Announces First Patient Dosed in Phase 2 Clinical Trial of NLY01 for Patients with Parkinson's Disease

Novel Mechanism of Action Inhibits Pathological Activation of Microglial Cells and Prevents Neuronal ... See more »

Social Media

D&D Pharmatech Headquarters

225-18, Pangyoyeok-ro Bundang-gu, Gyeonggi-do

Seongnam, Gyeonggido13494

82-31-8019-7771

Driving Directions »

Trending Companies

D&D Pharmatech Summary

ABOUT

Overview

D&D Pharmatech is a biotech company that develops and commercializes therapeutics for the treatment of neurodegenerative and fibrotic diseases. D&D Pharmatech was founded in 2014. D&D Pharmatech's headquarters is located in Seongnam, Gyeonggido, KR 13...

CEO

D&D Pharmatech's CEO, Sung Mook Lim, currently has an approval rating of 90%. D&D Pharmatech's primary competitors are SK Biopharmaceuticals, Orum Therapeutics & Dong-A ST.

Website

ddpharmatech.com

Frequently Asked Questions about D&D Pharmatech

  1. When was D&D Pharmatech founded?

    D&D Pharmatech was founded in 2014
  2. Who is D&D Pharmatech's CEO?

    D&D Pharmatech's CEO is Sung Mook Lim
  3. How much revenue does D&D Pharmatech generate?

    D&D Pharmatech generates $3.5M in revenue
  4. How much funding does D&D Pharmatech have?

    D&D Pharmatech has historically raised $155.9M in funding
  1. Where is D&D Pharmatech's headquarters?

    D&D Pharmatech's headquarters is in Seongnam Gyeonggido, KR
  2. How many employees does D&D Pharmatech have?

    D&D Pharmatech has 15 employees
  3. What sector does D&D Pharmatech operate in?

    D&D Pharmatech is in Pharmaceuticals
  4. Who are D&D Pharmatech's competitors?

    D&D Pharmatech's top competitors are SK Biopharmaceuticals, Orum Therapeutics, Dong-A ST